Preoperative Hematocrit Is Not Associated With Stroke After Surgery for Acute Type A Aortic Dissection.

Objective: To determine the impact of hematocrit on adverse neurologic events after acute type A aortic dissection (ATAAD) repair under deep hypothermic circulatory arrest.

Design: Retrospective study of consecutive aortic surgeries from 2010 to 2021.

Setting: Single institution.

Reintervention after aortic root replacement with allograft, xenograft, and stented bioprosthetic valves.

Background: There has been a significant increase in the utilization of non-mechanical valves in the aortic position over time. However, details in reinterventions after aortic root replacement (ARR) with non-mechanical prosthesis were limited in the literature, despite the potential importance of reinterventions in the lifetime management of aortic valve disease.

Methods: This is a single-center retrospective study, identifying all patients who underwent ARR with allograft, xenografts, and stented bioprosthetic valved conduit from 2010 to 2020.

Trends in Kidney Function and Chronic Kidney Disease after Surgery for Acute Type A Aortic Dissection.

Background: We sought to assess the effect of postoperative renal failure (RF) on outcomes of acute type A aortic dissection (ATAAD) and identify predictors of chronic kidney disease (CKD) following ATAAD.

Methods: This retrospective single-center analysis included all adults with ATAAD from 2011 to 2023. Patients were stratified into RF and no RF groups.

Diastolic Dysfunction and the Risk of Stroke and Major Bleeding.

Background: Left ventricular diastolic dysfunction (DD) is associated with adverse cardiovascular outcomes including atrial fibrillation. Whether DD is independently associated with incident stroke and transient ischemic attack (TIA) and with bleeding events is not known. We performed this observational cohort analysis to examine the impact of DD on the risk of stroke/TIA and major bleeding.

Medication optimization clinic decreases hospitalizations and mortality for patients with heart failure with reduced ejection fraction.

Study Objective: To evaluate the impact of a medication optimization clinic (MOC) on GDMT and outcomes for patients with HFrEF versus usual care.

Design: Retrospective evaluation of a multi-site MOC was conducted.

Setting: Large health system with academic and community hospitals.